Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
白细胞介素-2/干扰素-α2a/13-维甲酸化疗免疫疗法治疗晚期肾细胞癌：德国肾癌化疗免疫治疗协作组（DGCIN）前瞻性随机试验的结果
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/sj.bjc.6603271
Atzpodien, J; Kirchner, H; Rebmann, U; Soder, M; Gertenbach, U; Siebels, M; Roigas, J; Raschke, R; Salm, S; Schwindl, B; Müller, S C; Hauser, S; Leiber, C; Huland, E; Heinzer, H; Siemer, S; Metzner, B; Heynemann, H; Fornara, P; Reitz, M
